XC8

4'-fluoro-6-(trifluoromethyl)[1,1'-biphenyl]-2-yl 2-acetamido-2-deoxy-beta-D-galactopyranoside

Created:	2023-10-30
Last modified:	2024-02-14

Find Related PDB Entry
1 entries where XC8 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	5
Bond Count	55
Aromatic Bond Count	12

2D diagram of XC8

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4'-fluoro-6-(trifluoromethyl)[1,1'-biphenyl]-2-yl 2-acetamido-2-deoxy-beta-D-galactopyranoside
Systematic Name (OpenEye OEToolkits)	~{N}-[(2~{S},3~{R},4~{R},5~{R},6~{R})-2-[2-(4-fluorophenyl)-3-(trifluoromethyl)phenoxy]-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-3-yl]ethanamide
Formula	C₂₁ H₂₁ F₄ N O₆
Molecular Weight	459.388
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	FC(F)(F)c1cccc(OC2OC(CO)C(O)C(O)C2NC(C)=O)c1c1ccc(F)cc1
SMILES	CACTVS	3.385	CC(=O)N[CH]1[CH](O)[CH](O)[CH](CO)O[CH]1Oc2cccc(c2c3ccc(F)cc3)C(F)(F)F
SMILES	OpenEye OEToolkits	2.0.7	CC(=O)NC1C(C(C(OC1Oc2cccc(c2c3ccc(cc3)F)C(F)(F)F)CO)O)O
Canonical SMILES	CACTVS	3.385	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1Oc2cccc(c2c3ccc(F)cc3)C(F)(F)F
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1Oc2cccc(c2c3ccc(cc3)F)C(F)(F)F)CO)O)O
InChI	InChI	1.06	InChI=1S/C21H21F4NO6/c1-10(28)26-17-19(30)18(29)15(9-27)32-20(17)31-14-4-2-3-13(21(23,24)25)16(14)11-5-7-12(22)8-6-11/h2-8,15,17-20,27,29-30H,9H2,1H3,(H,26,28)/t15-,17-,18+,19-,20-/m1/s1
InChIKey	InChI	1.06	HRLDWJXNEKTIOQ-XIKSMUEASA-N

Related Resource References

Resource Name	Reference
PubChem	170459243

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.